Fuller & Thaler Asset Management, Inc. Trans Medics Group, Inc. Transaction History

Fuller & Thaler Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$135.68 - $176.11 $8.17 Million - $10.6 Million	60,192 Added 15.19%	456,522 $71.7 Million
Q2 2024 Aug 09, 2024	BUY	$72.62 - $150.62 $6.78 Million - $14.1 Million	93,323 Added 30.8%	396,330 $59.7 Million
Q1 2024 May 13, 2024	BUY	$70.86 - $89.93 $21.5 Million - $27.2 Million	303,007 New	303,007 $22.4 Million

347

30.6M

671K

858K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.18B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.